Nominee Director Agreement Template for the United States

Yes, a Nominee Director Agreement is legally binding in the United States when properly executed and compliant with federal securities laws and state corporate statutes. The agreement creates enforceable contractual obligations between the appointing party and the nominee director, subject to SEC regulations and Sarbanes-Oxley Act requirements for publicly traded companies. Courts will enforce these agreements provided they don't violate fiduciary duties or securities disclosure requirements.

Operating without a proper Nominee Director Agreement creates significant legal and compliance risks, especially for publicly traded companies subject to SEC regulations. Without this document, you lack clear contractual terms governing the nominee's duties, compensation, and decision-making authority, potentially violating securities disclosure requirements. Additionally, the absence of this agreement may expose both parties to personal liability and create conflicts with Sarbanes-Oxley Act governance standards.

SEC regulations under the Securities Exchange Act of 1934 require publicly traded companies to disclose material relationships with directors, including nominee arrangements, in proxy statements and Form 10-K filings. The Nominee Director Agreement must include provisions ensuring compliance with these disclosure obligations and may need to address independence requirements under Sarbanes-Oxley Act standards. Failure to properly disclose nominee director relationships can result in SEC enforcement actions and penalties.

A Nominee Director Agreement specifically addresses the nominee's obligation to represent the appointing party's interests and includes detailed provisions about decision-making authority and reporting requirements. Unlike a standard Director Appointment Letter, it must carefully balance the nominee's fiduciary duties to the corporation with their contractual obligations to the appointing party. The agreement also requires more complex SEC disclosure considerations and potential conflicts of interest management under federal securities laws.

Creating a comprehensive Nominee Director Agreement typically takes 1-3 weeks, depending on the complexity of the corporate structure and SEC compliance requirements. The process involves drafting the initial agreement, conducting legal review for securities law compliance, negotiating terms between parties, and ensuring alignment with Sarbanes-Oxley Act standards if applicable. More complex arrangements involving publicly traded companies or international operations may require additional time for regulatory review.

Yes, nominee directors can face personal liability under U.S. law if they breach their fiduciary duties to the corporation or violate securities regulations, despite their nominee status. The Sarbanes-Oxley Act and other federal laws hold directors personally accountable for certain corporate misconduct, regardless of whether they're acting as nominees. A properly drafted Nominee Director Agreement should include indemnification provisions and liability limitations while ensuring compliance with non-waivable legal duties.

Yes, nominee directors should absolutely be covered under the company's Directors and Officers (D&O) insurance policy to protect against personal liability exposure. Given the potential for SEC enforcement actions and securities litigation under federal law, adequate insurance coverage is essential for nominee directors. The Nominee Director Agreement should specify insurance coverage requirements and ensure the nominee director has the same protection as other board members under the company's D&O policy.